Pacer Advisors, Inc. Cue Biopharma, Inc. Transaction History

Pacer Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$10.9 - $14.53 $16,720 - $22,289	-1,534 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$11.2 - $16.09 $3,292 - $4,730	-294 Reduced 16.08%	1,534 $19,000
Q4 2020 Jan 20, 2021	BUY	$11.12 - $16.4 $9,385 - $13,841	844 Added 85.77%	1,828 $23,000
Q3 2020 Oct 19, 2020	BUY	$15.05 - $23.54 $14,809 - $23,163	984 New	984 $15,000

11.9M

22K

1.2K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $34.7M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.